SUS Surgical Science Sweden AB (publ)

5.871USD59.65 SEK · STO-0.42%Mkt Cap: 299.59M USDP/E: 28.54

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The c…

Institutional holders3 on file

Key Statistics

Company
Market Cap299.59M USD
Enterprise Value232.71M USD
Revenue (TTM)100.31M USD
Gross Profit64.73M USD
Net Income (TTM)6.58M USD
Revenue/Share1.96 USD
Last Price5.871 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees313
CountrySE
SectorHealthcare
IndustryHealth Information Services
ISINSE0014428512
Valuation
P/E (Trailing)28.54
P/E (Forward)12.25
PEG—
EV/EBITDA14.28
EV/Revenue2.32
P/S2.99
P/B0.65
EPS (TTM)0.21 USD
EPS (Forward)0.48 USD
52W Range
2.33359% of range8.367
52W High8.367 USD
52W Low2.333 USD
Profitability
Gross Margin66.28%
Oper. Margin13.08%
EBITDA Margin16.25%
Profit Margin6.73%
ROE1.56%
ROA1.42%
ROIC1.24%
ROCE1.57%
Growth
Revenue Growth-1.30%
Earnings Growth67.60%
Cash Flow & Leverage
Operating CF7.85M USD
CapEx (TTM)4.86M USD
FCF Margin-3.43%
FCF Yield-1.15%
Net Debt-66.15M USD
Net Debt/EBITDA-4.06
Net Debt/FCF—
Balance Sheet
Debt/Equity0.01
Current Ratio5.05
Quick Ratio3.64
Book Value/Sh9.02 USD
Cash/Share1.31 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split5:1
Split DateMay 25, 2020
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.107 USD
Upside (mean)+21.0%
Target Range5.906 USD – 8.367 USD
5.906+21.0% to mean8.367
# Analysts5
Ownership
Shares Out.51.03M
Float36.98M
Insiders29.35%
Institutions34.23%
Technical
SMA 505.378 (+9.2%)
SMA 2003.896 (+50.7%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)187.99K
Avg Vol (10d)326.85K
Technical Indicators
RSI (14)56.7
MACD1.1719
MACD Signal1.5427
MACD Hist.-0.3708
BB Upper6.158 USD
BB Middle5.813 USD
BB Lower5.467 USD
BB Width11.88%
ATR (14)0.2780 USD
Vol Ratio (20d)0.75x

About Surgical Science Sweden (STO: SUS)

›

Surgical Science Sweden (STO: SUS) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 313 employees.

The shares were at 59.65 SEK on 19 November 2026, down 28.1% over 52 weeks. Its 52-week range is 23.70 SEK to 85.00 SEK: the price is 29.8% below the high and 151.7% above the low.

At a market capitalisation of 3.04B SEK, it trades at 28.5 times trailing earnings and 12.2 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 32% for SUS.

Surgical Science Sweden reports return on equity of 1.6%, an operating margin of 13.1% and revenue down 1.3% year over year.

It holds more cash than debt, a net cash position of 672.06M SEK. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 72.20 SEK is 21.0% above the current price. The next earnings report is expected on 23 February 2027.